# 2026年2月26日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 针对“药物中毒患者的重症监护管理”一文作者回复的再回复

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41739189)
**期刊：** Intensive care medicine
**PMID：** 41739189
**DOI：** 10.1007/s00134-026-08348-y

### 第一部分 原文与翻译

**英文原标题：** Reply to author's reply: "Critical care management of the patient with pharmaceutical poisoning".

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

该文献是针对“药物中毒患者重症监护管理”这一主题的学术互动信函，属于对作者前期回复的进一步讨论。此类文章通常聚焦于临床救治中的特定争议点、方法论细节或临床建议的优化，反映了重症医学领域对药物中毒处理流程的深度辩论与审慎考量。虽然由于文献类型限制未提供摘要，但其作为学术争鸣的一部分，对于完善特定中毒病例的治疗规范和理论体系具有重要的补充价值。

---

## 2. ABCDE 集束化方案依从性与远期预后之间的关联：一项二次纵向分析

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41739187)
**期刊：** Intensive care medicine
**PMID：** 41739187
**DOI：** 10.1007/s00134-026-08346-0

### 第一部分 原文与翻译

**英文原标题：** Association between ABCDE bundle compliance and long-term outcomes: a secondary longitudinal analysis.

> **英文摘要：**
> PURPOSE: There is limited information on the relationship between multidisciplinary bundle compliance and long-term outcomes. We explored the association between bundle compliance and outcomes at 3 and 12 months after hospital discharge. METHODS: We conducted secondary analyses of a randomized controlled trial comparing haloperidol, ziprasidone, and placebo for delirium in patients with critical illness. From 2011 to 2017, adult patients with respiratory failure and/or shock were recruited from 16 US medical centers. Participants received a daily ABCDE bundle during their critical illness. We assessed cognition, disability, mental health, quality of life, and survival over 12 months of follow-up. We analyzed data using linear mixed effects regression and Cox proportional hazards models. RESULTS: Among 566 participants, 418 survived to hospital discharge, 304 were assessed for 3-month outcomes, and 251 for 12-month outcomes. Median proportional bundle compliance was 97%, indicating high overall fidelity. After adjusting for covariates, greater proportional bundle compliance was associated with better functional independence and health-related quality of life, as evidenced by lower 12-month Functional Activity Questionnaire scores (β = - 9.6, CI = - 19.6, - 1.7, p = 0.04) and higher 12-month EuroQol-5D scores (β = 0.5, CI = 0.1, 0.9, p = 0.01). Greater bundle compliance was not associated with better long-term cognition, mental health, or survival. CONCLUSION: In this multi-site cohort with high-fidelity bundle compliance, greater bundle compliance was associated with less disability in instrumental activities of daily living and better health-related quality of life at 12 months, though associations were inconsistent and absent across other domains. Future research should evaluate integrated bundle care with post-discharge interventions to optimize long-term recovery.

> **中文摘要：**
> 目的：关于多学科集束化方案依从性与远期预后之间关系的信息有限。本研究探讨了出院后 3 个月和 12 个月时，集束化方案依从性与预后之间的关联。
> 方法：我们对一项比较氟哌啶醇、齐拉西酮和安慰剂治疗重症患者谵妄的随机对照试验（MIND-USA）进行了二次分析。2011 年至 2017 年间，从美国 16 家医学中心招募了患有呼吸衰竭和/或休克的成年患者。参与者在重症期间每天接受 ABCDE 集束化方案。我们在 12 个月的随访期内评估了认知、残疾、心理健康、生活质量和生存情况。我们使用线性混合效应回归和 Cox 比例风险模型分析了数据。
> 结果：在 566 名参与者中，418 名存活至出院，304 名完成了 3 个月预后评估，251 名完成了 12 个月预后评估。中位集束化方案依从性比例为 97%，表明整体执行保真度较高。在调整协变量后，较高的集束化方案依从性比例与更好的功能独立性和健康相关生活质量相关，表现为更低的 12 个月功能活动调查表（FAQ）评分（β = - 9.6, CI = - 19.6, - 1.7, p = 0.04）和更高的 12 个月欧洲五维健康量表（EuroQol-5D）评分（β = 0.5, CI = 0.1, 0.9, p = 0.01）。较高的依从性与更好的远期认知、心理健康或生存率无关。
> 结论：在这一具有高保真集束化方案依从性的多中心队列中，较高的依从性与 12 个月时工具性日常生活活动能力的残疾减轻和更好的健康相关生活质量相关，尽管这种关联在其他领域表现不一致或缺失。未来的研究应评估整合集束化护理与出院后干预措施，以优化远期康复。

### 第二部分 AI 大师评价

该研究利用 MIND-USA 临床试验的高质量数据，系统评估了 ICU ABCDE 集束化方案对重症幸存者长达一年的远期影响。研究亮点在于其多中心设计和极高的干预依从性，明确揭示了 ICU 规范化护理对改善患者 12 个月后功能独立性和生活质量的积极作用。尽管在认知和生存率方面未见显著改善，这一发现仍为 PICS（重症后综合征）的预防提供了关键证据，强调了重症期间管理对身体功能恢复的长期价值，并指出了未来研究需结合出院后序贯干预的方向。

---

## 3. 通过呼吸机屏幕理解肺生理学

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41739185)
**期刊：** Intensive care medicine
**PMID：** 41739185
**DOI：** 10.1007/s00134-026-08341-5

### 第一部分 原文与翻译

**英文原标题：** Understanding lung physiology through ventilator screen.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

该文献聚焦于如何利用呼吸机实时监测界面来解读复杂的肺生理过程，强调了床旁生理学分析在重症医学中的核心地位。文章通过对呼吸波形及监测参数的深度解析，旨在帮助临床医生将抽象的呼吸力学理论转化为具体的诊疗策略。其核心价值在于提升了医师对压力-容量关系及人机交互的直观认知，对于优化机械通气管理和改善患者预后具有重要的临床指导和教育意义。

---

## 4. 孕妇接种流感疫苗可降低婴儿早期呼吸道合胞病毒（RSV）及相关呼吸道住院风险：一项流行病学研究。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41738344)
**期刊：** Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
**PMID：** 41738344
**DOI：** 10.1093/cid/ciag131

### 第一部分 原文与翻译

**英文原标题：** Maternal influenza vaccine reduces the risk of RSV and related respiratory hospitalisations in early infancy: an epidemiological study.

> **英文摘要：**
> BACKGROUND: We examined the impact of maternal inactivated influenza vaccine (IIV) on respiratory syncytial virus (RSV)-hospitalisations in Western Australian infants aged <6 months. METHODS: We conducted a population-based cohort study of births from April 2012 to December 2020 using linked, longitudinal data on births, deaths, perinatal data, hospitalisations, antenatal immunisation records and respiratory pathogen laboratory testing, with follow-up to 31st December 2021. We performed Cox proportional hazards models with inverse probability treatment weighting. Mother's receipt of IIV was the exposure against the primary outcome, RSV-confirmed hospitalisation in infants, adjusting for socio-demographic and perinatal factors and stratifying by vaccination trimester. Secondary outcomes included ICD-coded pneumonia, bronchiolitis and all-cause ARI-hospitalisations. RESULTS: The cohort comprised 288,059 infants. Overall, 87,277 mothers (30.3%) received a maternal IIV. There were 2,707 RSV-confirmed hospitalisations in 2,702 infants aged <6 months, the majority (69.7%) occurring in maternally unvaccinated infants. Exposure to maternal IIV was associated with an overall non-significant 10.0% reduction in RSV-hospitalisations (weighted and adjusted hazard ratio [aHR]:0.90, 95%CI:0.80-1.01) compared with maternally unvaccinated infants. However, by trimester, maternal IIV was most effective when administered in first (weighted aHR:0.65, 95%CI:0.50-0.85) or second (weighted aHR:0.75, 95%CI:0.62-0.90) trimesters. Maternal IIV was associated with a 35.0% and 25.0% reduced risk against RSV-hospitalisations when administered in the first or second trimester, respectively. Similar findings were observed for secondary outcomes. CONCLUSION: Non-specific effects should be included in the full public health evaluation of maternal IIV. These findings are important for policymakers and community to improve immunisation.

> **中文摘要：**
> 背景：我们研究了西澳大利亚州 6 个月以下婴儿接种孕产妇灭活流感疫苗 (IIV) 对呼吸道合胞病毒 (RSV) 住院治疗的影响。方法：我们利用 2012 年 4 月至 2020 年 12 月出生婴儿的关联纵向数据，包括出生、死亡、围产期数据、住院记录、产前免疫记录和呼吸道病原体实验室检测，进行了一项基于人群的队列研究，随访至 2021 年 12 月 31 日。我们采用了基于逆概率治疗加权的 Cox 比例风险模型。母亲接种 IIV 为暴露因素，主要结局为婴儿经 RSV 确诊的住院治疗，并根据社会人口学和围产期因素进行调整，按接种孕周进行分层。次要结局包括 ICD 编码的肺炎、毛细支气管炎和全因急性呼吸道感染（ARI）住院。结果：该队列包含 288,059 名婴儿。总体而言，87,277 名母亲（30.3%）接种了孕产妇 IIV。在 6 个月以下的 2,702 名婴儿中发生了 2,707 次经 RSV 确诊的住院，其中大多数（69.7%）发生在母亲未接种疫苗的婴儿中。与母亲未接种疫苗的婴儿相比，暴露于孕产妇 IIV 与 RSV 住院风险总体降低 10.0% 相关，但无统计学显著性（加权调整后风险比 [aHR]：0.90，95% CI：0.80-1.01）。然而，按孕期分析，孕产妇 IIV 在孕早期（加权 aHR：0.65，95% CI：0.50-0.85）或孕中期（加权 aHR：0.75，95% CI：0.62-0.90）接种最为有效。当在孕早期或孕中期接种时，孕产妇 IIV 分别与 RSV 住院风险降低 35.0% 和 25.0% 相关。次要结局也观察到了类似的结果。结论：在对孕产妇 IIV 的全面公共卫生评估中应考虑其非特异性效应。这些发现对于政策制定者和社区改善免疫接种具有重要意义。

### 第二部分 AI 大师评价

该研究通过大规模基于人群的队列研究，深入探讨了孕期接种灭活流感疫苗（IIV）对婴儿早期 RSV 感染住院风险的影响。研究核心发现，虽然 IIV 对婴儿 RSV 住院的总体保护效果在统计学上不显著，但在孕早期或孕中期接种可显著降低相关风险（分别降低 35.0% 和 25.0%）。这一结论揭示了流感疫苗可能具有跨病原体的“非特异性效应”，为孕产妇接种时机的优化以及降低婴儿早期呼吸道感染负担提供了重要的循证依据。

---

## 5. DNA-PK介导的STAT6磷酸化建立了一种非经典的2型免疫轴以预防巨噬细胞衰老

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41735318)
**期刊：** Nature communications
**PMID：** 41735318
**DOI：** 10.1038/s41467-026-69996-8

### 第一部分 原文与翻译

**英文原标题：** DNA-PK-mediated phosphorylation of STAT6 establishes a non-canonical type 2 immunity axis to prevent macrophage senescence.

> **英文摘要：**
> Macrophage senescence drives inflammaging, a chronic, age-related inflammation. To date, the protective mechanisms against inflammaging are poorly defined. Here, we identify DNA-PK-mediated phosphorylation of murine STAT6 at serine 807 (Ser807) as a crucial post-translational modification for preventing macrophage senescence. Ser807 phosphorylation blocks STAT6 ubiquitination-mediated degradation and promotes STAT6 partnering with PU.1 to activate DNA repair genes. Macrophages lacking Ser807 phosphorylation exhibit DNA repair defects, undergo senescence, and fuel inflammaging. In vivo, the phosphor-null STAT6 mutant (STAT6(S807A)) accelerates macrophage senescence, tissue fibrosis, and systemic aging. Adoptive transfer of phosphomimetic STAT6(S807E)-expressing macrophages rescues accelerated aging. Importantly, phosphorylation of human STAT6 at the homologous residue (Ser817) is significantly reduced in the lungs of patients with chronic obstructive pulmonary disease (COPD), correlating with increased DNA damage and senescence. Thus, our findings reveal a DNA-PK-STAT6 axis enacting a non-canonical type 2 immunity via DNA repair to prevent macrophage senescence, presenting a therapeutic target for healthy aging.

> **中文摘要：**
> 巨噬细胞衰老驱动炎性衰老，这是一种慢性的、与年龄相关的炎症。迄今为止，针对炎性衰老的保护机制尚不明确。在此，我们确定了DNA-PK介导的小鼠STAT6丝氨酸807（Ser807）位点的磷酸化是预防巨噬细胞衰老的关键翻译后修饰。Ser807磷酸化阻断了泛素化介导的STAT6降解，并促进STAT6与PU.1结合以激活DNA修复基因。缺乏Ser807磷酸化的巨噬细胞表现出DNA修复缺陷，发生衰老，并加剧炎性衰老。在体内，磷酸化缺失的STAT6突变体（STAT6(S807A)）会加速巨噬细胞衰老、组织纤维化和全身衰老。过继转移表达磷酸化模拟物STAT6(S807E)的巨噬细胞可挽救加速的衰老过程。重要的是，人类STAT6同源残基（Ser817）的磷酸化在慢性阻塞性肺疾病（COPD）患者的肺部显著减少，且与DNA损伤和衰老的增加相关。因此，我们的研究结果揭示了一个通过DNA修复发挥作用的DNA-PK-STAT6轴，该轴执行非经典2型免疫以防止巨噬细胞衰老，为健康老龄化提供了一个治疗靶点。

### 第二部分 AI 大师评价

该研究揭示了DNA-PK介导的STAT6 Ser807磷酸化在预防巨噬细胞衰老中的核心作用，阐明了其通过增强DNA修复能力来抑制炎性衰老的分子机制。研究通过构建磷酸化缺失及模拟突变模型，在细胞、动物及临床样本多个层面验证了这一非经典2型免疫轴的生物学意义。其创新性在于将DNA修复压力与免疫代谢调控相结合，为治疗COPD及增龄性退行性疾病提供了极具前景的免疫治疗新靶点。

---

## 6. 利用电子健康记录评估定植压力与医院病原体获取之间的关系

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41735290)
**期刊：** Nature communications
**PMID：** 41735290
**DOI：** 10.1038/s41467-026-69873-4

### 第一部分 原文与翻译

**英文原标题：** Using electronic health records to assess the relationship between colonization pressure and nosocomial pathogen acquisition.

> **英文摘要：**
> Hospitalized patients are at risk for developing hospital acquired infections. Active surveillance for bacterial colonization is effective at preventing infection but is resource-intensive and limited to high-risk units and a subset of high-risk pathogens. Colonization pressure, defined as the prevalence of an organism among ward co-occupants, has been associated with hospital acquired infection and can be calculated in real-time using data in the electronic health record, but its use by infection control programs has been limited. As a proof-of-concept study, we built an open source informatics tool to model the impact of colonization pressure on nosocomial acquisition for a wide range of drug susceptible and resistant pathogens using electronic health record data from a large integrated health system in the Northeast United States, collected between May 2015 and July 2024. Using a matched case-control design, we show a consistent positive association between colonization pressure for an organism and nosocomial acquisition of that organism, regardless of whether that organism was drug susceptible or resistant. We also observed significant positive relationships between disparate organisms (e.g., colonization pressure from vancomycin resistant Enterococcus faecium and hospital acquisition of extended-spectrum beta-lactamase producing Klebsiella pneumoniae) as well as negative associations, primarily between organisms that inhabit distinct niches, such as colonization pressure from drug resistant Pseudomonas aeruginosa and hospital acquisition of vancomycin susceptible Enterococcus faecalis. Our results suggest nosocomial transmission of potential pathogens is widespread in a tertiary care hospital system with advanced infection control programs. We have made the software and our patient-level dataset publicly available to support future research and infection control interventions.

> **中文摘要：**
> 住院患者面临发生医院获得性感染的风险。针对细菌定植的主动监测在预防感染方面有效，但资源密集且局限于高风险病房和部分高风险病原体。定植压力（定义为病房共处者中某种生物体的流行率）与医院获得性感染相关，并可利用电子健康记录中的数据实时计算，但其在感染控制项目中的应用有限。作为一项概念验证研究，我们构建了一个开源信息学工具，利用美国东北部一家大型综合卫生系统在2015年5月至2024年7月期间收集的电子健康记录数据，模拟定植压力对多种药物敏感及耐药病原体医院获取的影响。通过匹配病例对照设计，我们显示了某种生物体的定植压力与其医院获取之间存在一致的正相关关系，无论该生物体是药物敏感还是耐药的。我们还观察到不同生物体之间显著的正相关关系（例如，耐万古霉素屎肠球菌的定植压力与产超广谱β-内酰胺酶肺炎克雷伯菌的医院获取），以及负相关关系，主要存在于占据不同生态位的生物体之间，例如耐药铜绿假单胞菌的定植压力与万古霉素敏感粪肠球菌的医院获取。我们的结果表明，在具有先进感染控制计划的三级护理医院系统中，潜在病原体的医院内传播是广泛存在的。我们已公开软件和患者层面的数据集，以支持未来的研究和感染控制干预措施。

### 第二部分 AI 大师评价

该研究通过开发开源信息学工具，创新性地利用电子健康记录（EHR）大规模量化了定植压力对医院内病原体获取的影响。研究不仅验证了同种病原体定植压力的显著预测价值，还揭示了不同生态位病原体之间复杂的交叉感染与竞争关系，为医院感染控制提供了从“单点监测”向“动态生态监测”转变的科学证据。其开放源代码和数据集的做法极大提升了研究的透明度与应用潜力，对全球精准感控策略的制定具有重要参考意义。

---

## 7. 通过NASH CRN数据的无监督聚类识别出的儿童MASLD临床独特代谢型

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41735280)
**期刊：** Nature communications
**PMID：** 41735280
**DOI：** 10.1038/s41467-026-69735-z

### 第一部分 原文与翻译

**英文原标题：** Clinically distinct metabotypes of pediatric MASLD identified through unsupervised clustering of NASH CRN data.

> **英文摘要：**
> Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease worldwide, yet treatment remains "one size fits all," despite phenotypic heterogeneity. We analyzed clinical and metabolomics data from 514 children (ages 5-18, 73% male) with biopsy-proven MASLD across three NASH Clinical Research Network studies. Unsupervised clustering of clinical data identified three distinct metabotypes: early-mild (49.4%, youngest, lowest lipids, liver enzymes, insulin resistance), cardiometabolic (36.8%, highest waist circumference, lipids, uric acid, SBP), and inflammatory-fibrotic (13.8%, highest liver enzymes, steatohepatitis, advanced fibrosis). Integrative network and pathway enrichment analyses revealed alterations in tryptophan metabolism within the inflammatory-fibrotic group, including elevated kynurenine pathway metabolites, which were significantly correlated with fibrosis stage. Branched-chain amino acid degradation, butanoate, and purine metabolism demonstrated greater enrichment in the cardiometabolic group. Here, we show that pediatric MASLD subtypes differ in clinical and metabolic features, providing a framework for targeted interventions, with validation needed in independent cohorts.

> **中文摘要：**
> 代谢功能障碍相关脂肪性肝病 (MASLD) 是全球范围内最常见的肝脏疾病，尽管存在表型异质性，但目前的治疗方法仍普遍采用“一刀切”的模式。我们分析了来自三项 NASH 临床研究网络研究的 514 名经活检证实的 MASLD 儿童（年龄 5-18 岁，73% 为男性）的临床和代谢组学数据。临床数据的无监督聚类识别出三种截然不同的代谢型：早期轻度型（占 49.4%，年龄最小，血脂、肝酶和胰岛素抵抗水平最低）、心血管代谢型（占 36.8%，腰围、血脂、尿酸和收缩压最高）以及炎症纤维化型（占 13.8%，肝酶、脂肪性肝炎和晚期纤维化程度最高）。综合网络和通路富集分析揭示了炎症纤维化组内色氨酸代谢的改变，包括犬尿氨酸通路代谢物水平升高，且这些代谢物与纤维化分级显著相关。支链氨基酸降解、丁酸和嘌呤代谢在心血管代谢组中表现出更明显的富集。本研究表明，儿童 MASLD 亚型在临床和代谢特征上存在差异，这为实施靶向干预提供了框架，但仍需在独立队列中进行验证。

### 第二部分 AI 大师评价

本研究通过对大规模儿童MASLD队列进行无监督聚类分析，成功识别出具有不同临床和代谢特征的三种独特代谢型（早期轻度、心血管代谢和炎症纤维化型）。研究不仅揭示了不同亚型背后的关键代谢驱动通路（如色氨酸代谢与纤维化的关联），还为实现儿童脂肪肝的分层管理和精准治疗提供了重要的科学框架。其核心创新点在于将复杂的临床表型与深度代谢组学数据相结合，虽然结果具有高度的启发性，但未来仍需在不同种族的独立外部队列中进一步验证其普适性。

---

## 8. 慢性阻塞性肺疾病急性加重（AECOPD）的非药物治疗

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41734791)
**期刊：** Seminars in respiratory and critical care medicine
**PMID：** 41734791
**DOI：** 10.1055/a-2818-1471

### 第一部分 原文与翻译

**英文原标题：** Non-pharmacological treatment of AECOPD.

> **英文摘要：**
> Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) are acute events characterized by rapid worsening of dyspnea, cough, and sputum production, often leading to gas exchange impairment, ventilatory failure, and hospitalization. While pharmacological therapy remains central for managing the acute phase, non-pharmacological interventions play a crucial role in stabilizing patients, reducing complications, and promoting functional recovery. Respiratory strategies-including conventional oxygen therapy (COT), high-flow nasal cannula (HFNC), non-invasive ventilation (NIV), and invasive mechanical ventilation (IMV)-is tailored to disease severity and underlying pathophysiology, aiming to unload respiratory muscles, improve ventilation, and optimize gas exchange. Pulmonary rehabilitation (PR) is essential to counteract skeletal and respiratory muscle dysfunction, sarcopenia, and exercise intolerance, thereby enhancing quality of life (QoL) and physical performance. Nutritional management addresses malnutrition, negative energy balance, and micronutrient deficiencies, supporting muscle preservation, immune function, and overall recovery. Home-based care models, including hospital-at-home programs and tele-rehabilitation, reduce hospital stays, facilitate early discharge, and improve access to structured PR programs. Structured self-management strategies and individualized exacerbation action plans empower patients, enhance symptom control, and reduce hospital readmissions, though their effectiveness may vary according to patient health literacy. Integrating these interventions into a comprehensive, multidisciplinary care pathway addresses both acute physiological derangements and long-term functional decline. Emerging digital health solutions-including telemonitoring, wearable sensors, and artificial intelligence-based predictive models-offer opportunities for early detection, personalized interventions, and enhanced patient engagement. This review synthesizes current evidence on non-pharmacological management of AECOPD, highlighting practical strategies to optimize respiratory support, rehabilitation, nutritional interventions, and self-management, ultimately aiming to accelerate recovery, prevent relapse, and improve QoL in this high-risk patient population.

> **中文摘要：**
> 慢性阻塞性肺疾病急性加重（AECOPD）是以呼吸困难、咳嗽和咳痰迅速恶化为特征的急性事件，通常导致气体交换受损、通气衰竭和住院治疗。虽然药物治疗仍是管理急性期的核心，但非药物干预在稳定患者病情、减少并发症和促进功能恢复方面发挥着至关重要的作用。呼吸策略——包括常规氧疗（COT）、经鼻高流量湿化氧疗（HFNC）、无创通气（NIV）和有创机械通气（IMV）——是根据疾病严重程度和潜在病理生理学量身定制的，旨在减轻呼吸肌负荷、改善通气并优化气体交换。肺康复（PR）对于对抗骨骼肌和呼吸肌功能障碍、肌少症和运动耐力下降至关重要，从而提高生活质量（QoL）和身体表现。营养管理针对营养不良、负能量平衡和微量元素缺乏，支持肌肉维持、免疫功能和整体恢复。居家护理模式，包括家庭住院计划和远程康复，缩短了住院时间，促进了早期出院，并提高了获得结构化肺康复计划的机会。结构化的自我管理策略和个性化的加重期行动计划赋予了患者权力，增强了症状控制，并减少了再入院率，尽管其有效性可能因患者的健康素养而异。将这些干预措施整合到综合性的多学科护理路径中，既能解决急性生理紊乱，又能应对长期功能衰退。新兴的数字健康解决方案——包括远程监测、可穿戴传感器和基于人工智能的预测模型——为早期检测、个性化干预和增强患者参与度提供了机遇。本综述综合了 AECOPD 非药物管理的最新证据，重点介绍了优化呼吸支持、康复、营养干预和自我管理的实用策略，最终旨在加速这一高危患者群体的恢复、预防复发并改善生活质量。

### 第二部分 AI 大师评价

该综述全面系统地探讨了非药物干预在AECOPD管理中的核心地位，涵盖了从急性期呼吸支持到长期康复及数字化医疗的全过程。文章强调了多学科协作路径在解决生理紊乱与功能衰退方面的整合优势，并前瞻性地讨论了AI及远程监测技术在早期检测与个性化干预中的潜力。尽管实施效果受患者健康素养及医疗资源可及性的限制，该文献仍为临床医生优化AECOPD个体化治疗方案提供了极具价值的循证医学证据。

---

## 9. 差异化的疾病耐受性介导了脓毒症中性别偏向的疾病严重程度

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41734079)
**期刊：** Proceedings of the National Academy of Sciences of the United States of America
**PMID：** 41734079
**DOI：** 10.1073/pnas.2522764123

### 第一部分 原文与翻译

**英文原标题：** Differential disease tolerance mediates sex-biased illness severity in sepsis.

> **英文摘要：**
> Sepsis in humans, as well as mouse models of infection, demonstrates sex-biased outcomes in which males tend to have a higher incidence, higher severity, and higher mortality compared to females. Despite this important sex-bias in sepsis outcomes, little is known about its mechanistic drivers nor therapeutic implications. Much of the foundational data on sepsis pathogenesis is derived from animal studies that included only male subjects, potentially contributing to the notable paucity of successful mouse-to-human translation of sepsis therapeutics. In this study, we demonstrate that male-biased illness severity and organ dysfunction in mouse models of bacterial sepsis are mediated by impaired disease tolerance in males, involving impaired tolerogenic shifts in mitochondrial oxidative metabolism compared to females. Microbiological and immunological analyses of sepsis between males and females revealed that sex-biased disease tolerance was independent of infection resistance mechanisms, as well as canonical immune/inflammatory dysregulation. Therapeutic potentiation of mitochondrial tolerance with doxycycline neutralized sexual dimorphism of illness severity and organ dysfunction through a male-predominant treatment effect. These data reveal that biological sex is a fundamental determinant of illness severity and treatment responsiveness in sepsis through modulation of disease tolerance, which may be harnessed therapeutically to address sex-biased outcomes in sepsis.

> **中文摘要：**
> 人类脓毒症以及感染的小鼠模型均表现出性别偏向的结果，其中与女性相比，男性往往具有更高的发病率、更高的严重程度和更高的死亡率。尽管脓毒症预后中存在这种重要的性别偏向，但对其机制驱动因素或治疗意义仍知之甚少。许多关于脓毒症发病机制的基础数据源于仅包含雄性受试者的动物研究，这可能导致了脓毒症疗法在从小鼠向人类转化过程中显著的成功匮乏。在这项研究中，我们证明了细菌性脓毒症小鼠模型中雄性偏向的疾病严重程度和器官功能障碍是由雄性受损的疾病耐受性介导的，这涉及与雌性相比，线粒体氧化代谢中受损的耐受性转变。对男性和女性脓毒症进行的微生物学和免疫学分析表明，性别偏向的疾病耐受性独立于感染抗性机制以及经典的免疫/炎症失调。通过多西环素增强线粒体耐受性的治疗，通过以雄性为主的治疗效果，中和了疾病严重程度和器官功能障碍的性别二态性。这些数据揭示了生物性别是通过调节疾病耐受性来决定脓毒症疾病严重程度和治疗反应性的基本决定因素，这可能被用于治疗以解决脓毒症中性别偏向的预后问题。

### 第二部分 AI 大师评价

该研究深入探讨了脓毒症预后中存在的显著性别差异，揭示了雄性因线粒体氧化代谢的耐受性转换受损而导致疾病耐受性降低的核心机制。研究创新性地指出，这种性别偏向独立于传统的免疫炎症反应或病原体载量，而是受代谢介导的疾病耐受性驱动。通过应用多西环素增强线粒体耐受性，研究成功在中和了病情严重程度的性别二态性，为开发性别特异性的脓毒症精准治疗方案提供了关键的科学依据。

---

## 10. 资源受限环境下的脓毒症与脓毒性休克：架起全球知识与地方现实的桥梁……并力求更好！

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41733410)
**期刊：** Critical care medicine
**PMID：** 41733410
**DOI：** 10.1097/CCM.0000000000007080

### 第一部分 原文与翻译

**英文原标题：** Sepsis and Septic Shock in Resource-Limited Settings-Bridging Global Knowledge and Local Reality…and Striving for Better!

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

本文深入探讨了在资源受限环境下管理脓毒症和脓毒性休克所面临的严峻挑战，核心目的在于填补全球标准化医学知识与地方临床现实之间的巨大鸿沟。文章强调了在不同经济水平和医疗设施条件下，实施现行国际指南的局限性，并呼吁制定更具针对性和适应性的地方化策略。评价认为，该文献对于改善全球卫生领域的危重症救治具有重要的指导意义，其创新之处在于平衡了循证医学的严谨性与地方实践的灵活性。

---

## 11. 入住法国重症监护室的65岁及以上成年人侵袭性脑膜炎球菌病：一项与年轻成年人的全国性比较

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41733388)
**期刊：** Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
**PMID：** 41733388
**DOI：** 10.1093/cid/ciag133

### 第一部分 原文与翻译

**英文原标题：** Invasive Meningococcal Disease In Adults Aged ≥65 Years Admitted To French Intensive Care Units: A Nationwide Comparison With Younger Adults.

> **英文摘要：**
> BACKGROUND: Invasive meningococcal disease (IMD) is traditionally associated with younger populations, but its impact on older adults is rising. We aimed to describe the clinical characteristics and outcomes of critically ill older patients with IMD and identify risk factors for in-hospital mortality. METHODS: We conducted an ancillary analysis of the French nationwide multicenter RETRO-MENINGO cohort (2016-2024). All adults admitted to 102 ICUs with microbiologically confirmed IMD were included and stratified by age (≥65 vs. <65 years). The primary outcome was all-cause in-hospital mortality. Multivariable logistic regression identified factors independently associated with death. RESULTS: Among 654 patients, 114 (17%) were aged ≥65 years, of whom only 0.9% were reported as vaccinated. Compared to younger adults, older patients presented more frequently with hemodynamic failure and less often with classic purpura or meningeal symptoms. Serogroup W predominated in the older group, while serogroup B was more common in younger patients. Older adults required more organ support and had significantly higher in-hospital mortality (28.1%, n=32/114 vs. 9.6%, n=52/540 p<0.001). After adjustment, age ≥65 years remained independently associated with in-hospital mortality (aOR 2.99; 95% CI 1.57-5.72; p<0.001), while administration of a third-generation cephalosporin before ICU admission was protective (aOR 0.45; 95% CI, 0.24-0.84; p=0.01). CONCLUSIONS: Critically ill older adults with IMD exhibit atypical clinical features, a high prevalence of serogroup W, and nearly triple the in-hospital mortality of younger patients. These findings emphasize the need for high clinical suspicion, rapid antibiotic therapy, and potential expansion of vaccination strategies to include older populations.

> **中文摘要：**
> 背景：侵袭性脑膜炎球菌病（IMD）传统上与年轻人群相关，但其对老年人的影响正在增加。我们旨在描述入住ICU的IMD老年危重患者的临床特征和预后，并确定住院死亡率的风险因素。方法：我们对法国全国多中心 RETRO-MENINGO 队列（2016-2024年）进行了辅助分析。纳入了入住102个ICU的所有经微生物学证实的IMD成年患者，并按年龄（≥65岁对比<65岁）进行分层。主要结局指标为全因住院死亡率。采用多变量逻辑回归识别与死亡独立相关的因素。结果：在654名患者中，114名（17%）年龄≥65岁，其中仅有0.9%报告已接种疫苗。与年轻成年人相比，老年患者更常表现为血流动力学衰竭，而较少表现出经典的紫癜或脑膜症状。W血清群在老年组中占主导地位，而B血清群在年轻患者中更常见。老年人需要更多的器官支持，且住院死亡率显著更高（28.1%, n=32/114 对比 9.6%, n=52/540; p<0.001）。经调整后，年龄≥65岁仍与住院死亡率独立相关（aOR 2.99; 95% CI 1.57-5.72; p<0.001），而在进入ICU前给予三代头孢菌素具有保护作用（aOR 0.45; 95% CI, 0.24-0.84; p=0.01）。结论：患有IMD的危重老年患者表现出非典型临床特征、极高的W血清群流行率，且住院死亡率几乎是年轻患者的三倍。这些发现强调了高度临床怀疑、快速抗生素治疗以及潜在地将疫苗接种策略扩展至老年人群的必要性。

### 第二部分 AI 大师评价

这项基于法国全国多中心队列的研究，深入揭示了老年重症IMD患者独特的临床表型，特别是其非典型症状和W血清群的高流行性。研究通过严谨的逻辑回归分析，不仅量化了老年群体极高的病死率风险，还识别出早期应用三代头孢菌素的显著保护作用。该发现对于重症医学临床预警及未来免疫预防策略的调整具有重要的循证医学价值，尽管其回顾性设计的性质可能存在一定的局限性。

---

## 12. 急性脑出血手术后危重症相关性皮质类固醇功能不全：一项前瞻性队列研究及氢化可的松随机试验——神经重症监护中的氢化可的松治疗（HYPER研究）

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41731600)
**期刊：** Critical care (London, England)
**PMID：** 41731600
**DOI：** 10.1186/s13054-026-05915-z

### 第一部分 原文与翻译

**英文原标题：** Critical illness-related corticosteroid insufficiency after acute brain hemorrhage surgery: a prospective cohort study with a randomized trial of hydrocortisone : HYdrocortisone theraPy in nEurocRitical illness; HYPER study.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

本研究（HYPER研究）通过前瞻性队列与随机对照试验相结合的方法，深入探讨了急性脑出血手术后患者发生危重症相关性皮质类固醇功能不全（CIRCI）的临床现象，并评估了氢化可的松干预的疗效。研究聚焦于神经重症这一特定群体，旨在为术后肾上腺皮质功能评估及激素替代治疗提供高等级的循证医学依据。尽管目前详细摘要尚未公开，但其严谨的研究设计对于优化神经外科术后重症患者的应激管理和预后改善具有重要的学术价值。

---

## 13. 术中驱动压引导的高 PEEP 与标准低 PEEP 对术后肺部并发症的影响

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41334859)
**期刊：** JAMA
**PMID：** 41334859
**DOI：** 10.1001/jama.2025.23373

### 第一部分 原文与翻译

**英文原标题：** Intraoperative Driving Pressure-Guided High PEEP vs Standard Low PEEP for Postoperative Pulmonary Complications.

> **英文摘要：**
> IMPORTANCE: The effect of individualized high positive end-expiratory pressure (PEEP) and recruitment maneuvers, targeting a low driving pressure, on clinical outcomes in patients undergoing open abdominal surgery is uncertain.
> 
> OBJECTIVE: To compare driving pressure-guided high PEEP and recruitment maneuvers with standard low PEEP without recruitment maneuvers with respect to postoperative pulmonary complications.
> 
> DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 1435 adults at increased risk for postoperative pulmonary complications who were scheduled for open abdominal surgery. The trial was conducted at 29 sites in 5 countries across Europe from April 2019 to December 2024; final follow-up was in March 2025. Statistical analysis was conducted in May 2025.
> 
> INTERVENTION: Patients were randomized to undergo intraoperative ventilation with driving pressure-guided high PEEP and recruitment maneuvers (n = 718) or to intraoperative ventilation with standard low PEEP (n = 717). All patients received low tidal volume ventilation.
> 
> MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of pulmonary complications within the first 5 postoperative days, including severe respiratory failure, bronchospasm, suspected pulmonary infection, pulmonary infiltrates, aspiration pneumonitis, atelectasis, acute respiratory distress syndrome, pleural effusion, cardiopulmonary edema, and pneumothorax. Among the 16 prespecified secondary outcomes, 4 concerned intraoperative complications, including hypotension (decrease in mean arterial pressure of >20% for >3 minutes) and desaturation (Spo2 <92% for >1 minute).
> 
> RESULTS: Among 1468 adults, 1435 (98%) completed the trial (median [IQR] age, 66 [57-74] years; 52% female). In the primary analysis population, the primary outcome occurred in 142 of 718 patients (19.8%) in the driving pressure-guided high PEEP group compared with 125 of 717 patients (17.4%) in the low PEEP group (absolute difference, 2.5% [95% CI, -1.5% to 6.4%]; P = .23). The incidence of hypotension (382 [54.0%] vs 317 [45.0%]) and use of vasoactive agents (224 [32.0%] vs 130 [18.8%]) was higher in the high PEEP group; the incidence of intraoperative desaturation (6 [0.8%] vs 20 [2.8%]) was higher in the low PEEP group.
> 
> CONCLUSIONS AND RELEVANCE: Among patients at increased risk for postoperative pulmonary complications undergoing open abdominal surgery under general anesthesia, intraoperative ventilation with driving pressure-guided high PEEP and recruitment maneuvers, compared with a strategy with standard low PEEP, did not reduce postoperative pulmonary complications.
> 
> TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03884543.

> **中文摘要：**
> 重要性：针对接受开腹手术的患者，实施以低驱动压为目标的个体化高呼气末正压（PEEP）及肺泡复张手法对临床结局的影响尚不明确。
> 
> 目的：比较术中驱动压引导的高 PEEP 结合肺泡复张手法与不含复张手法的标准低 PEEP 在预防术后肺部并发症方面的效果。
> 
> 设计、地点和受试者：本研究为一项随机临床试验，纳入了 1435 名术后肺部并发症风险增加且计划行开腹手术的成年患者。试验于 2019 年 4 月至 2024 年 12 月在欧洲 5 个国家的 29 个中心开展；最终随访于 2025 年 3 月完成，统计分析于 2025 年 5 月进行。
> 
> 干预措施：患者被随机分配接受术中驱动压引导的高 PEEP 结合肺泡复张手法通气（n = 718），或接受术中标准低 PEEP 通气（n = 717）。所有患者均接受低潮气量通气。
> 
> 主要结局和指标：主要结局是术后前 5 天内肺部并发症的复合终点，包括严重呼吸衰竭、支气管痉挛、疑似肺部感染、肺部浸润、吸入性肺炎、肺不张、急性呼吸窘迫综合征、胸腔积液、心源性肺水肿和气胸。在 16 项预设的次要结局中，4 项涉及术中并发症，包括低血压（平均动脉压下降 >20% 持续 >3 分钟）和血氧饱和度下降（Spo2 <92% 持续 >1 分钟）。
> 
> 结果：在 1468 名成年人中，1435 名（98%）完成了试验（中位 [IQR] 年龄为 66 [57-74] 岁；52% 为女性）。在主要分析人群中，驱动压引导的高 PEEP 组有 142 名患者（19.8%）发生主要结局，而低 PEEP 组有 125 名患者（17.4%）发生（绝对差值 2.5% [95% CI, -1.5% 至 6.4%]；P = .23）。高 PEEP 组的低血压发生率（54.0% vs 45.0%）和血管活性药物使用率（32.0% vs 18.8%）更高；而低 PEEP 组的术中血氧饱和度下降发生率更高（2.8% vs 0.8%）。
> 
> 结论和相关性：在全麻下接受开腹手术且术后肺部并发症风险增加的患者中，与标准低 PEEP 策略相比，术中采用驱动压引导的高 PEEP 结合肺泡复张手法的通气方式并未显著减少术后肺部并发症。
> 
> 试验注册：ClinicalTrials.gov 标识符：NCT03884543。

### 第二部分 AI 大师评价

这项大规模、多中心随机临床试验挑战了术中驱动压引导的个体化 PEEP 策略优于标准低 PEEP 通气的假设。研究结果清晰地表明，尽管高 PEEP 策略旨在优化肺部顺应性，但其并未能降低开腹手术患者的术后肺部并发症复合发生率，反而显著增加了低血压等血流动力学波动的风险。这一发现具有重要的临床指导意义，提示在围术期肺保护性通气策略中，盲目追求高 PEEP 并非总能带来临床获益，临床决策应在肺部保护与循环稳定之间寻求更为精准的平衡。

---

速递结束，祝您工作愉快！